Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis.

Breau RH, Karnes RJ, Farmer SA, Thapa P, Cagiannos I, Morash C, Frank I.

BJU Int. 2014 Jun;113(6):900-6. doi: 10.1111/bju.12403. Epub 2013 Nov 27.

PMID:
24053569
[PubMed - indexed for MEDLINE]
2.

Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.

Tollefson MK, Boorjian SA, Farmer SA, Frank I.

World J Urol. 2012 Dec;30(6):795-9. doi: 10.1007/s00345-012-0855-8. Epub 2012 Mar 25.

PMID:
22447397
[PubMed - indexed for MEDLINE]
3.

Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.

Ma B, Li H, Zhang C, Yang K, Qiao B, Zhang Z, Xu Y.

Eur J Surg Oncol. 2013 Oct;39(10):1150-6. doi: 10.1016/j.ejso.2013.04.006. Epub 2013 May 27.

PMID:
23721764
[PubMed - indexed for MEDLINE]
4.

Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors.

Türkölmez K, Tokgöz H, Reşorlu B, Köse K, Bedük Y.

Urology. 2007 Sep;70(3):477-81.

PMID:
17905100
[PubMed - indexed for MEDLINE]
5.

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID:
16813876
[PubMed - indexed for MEDLINE]
6.

[Radical cystectomy in the treatment of bladder cancer always in due time?].

May M, Braun KP, Richter W, Helke C, Vogler H, Hoschke B, Siegsmund M.

Urologe A. 2007 Aug;46(8):913-9. German.

PMID:
17676301
[PubMed - indexed for MEDLINE]
7.

Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.

May M, Helke C, Nitzke T, Vogler H, Hoschke B.

Urol Int. 2004;72(2):103-11.

PMID:
14963349
[PubMed - indexed for MEDLINE]
8.

Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.

Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.

J Urol. 2007 Dec;178(6):2291-6; discussion 2296. Epub 2007 Oct 22.

PMID:
17936818
[PubMed - indexed for MEDLINE]
9.

Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.

Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Dalbagni G.

BJU Int. 2013 Jul;112(1):54-9. doi: 10.1111/j.1464-410X.2012.11391.x. Epub 2012 Nov 13.

PMID:
23146082
[PubMed - indexed for MEDLINE]
10.

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.

Urology. 2007 Sep;70(3):482-6.

PMID:
17905101
[PubMed - indexed for MEDLINE]
11.

An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma.

Sánchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB.

J Urol. 2003 Jan;169(1):110-5; discussion 115.

PMID:
12478115
[PubMed - indexed for MEDLINE]
12.

[Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder].

May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Müller O, Bretschneider-Ehrenberg P, Zacharias M, Gunia S, Bastian PJ.

Urologe A. 2011 Jul;50(7):821-9. doi: 10.1007/s00120-011-2507-9. German.

PMID:
21340593
[PubMed - indexed for MEDLINE]
13.

Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.

Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.

J Urol. 2009 Jul;182(1):78-84; discussion 84. doi: 10.1016/j.juro.2009.02.125. Epub 2009 May 17.

PMID:
19447418
[PubMed - indexed for MEDLINE]
14.

The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.

Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.

BJU Int. 2004 Dec;94(9):1258-62.

PMID:
15610101
[PubMed - indexed for MEDLINE]
15.

[Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].

Huguet J, Gaya JM, Sabaté S, Palou J, Villavicencio H.

Actas Urol Esp. 2010 Jan;34(1):63-70. Spanish.

PMID:
20223134
[PubMed - indexed for MEDLINE]
16.

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?

Beukers W, Meijer T, Vissers CJ, Boormans JL, Zwarthoff EC, van Leenders GJ.

Virchows Arch. 2012 Aug;461(2):149-56. doi: 10.1007/s00428-012-1277-0. Epub 2012 Jul 10.

PMID:
22777576
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.

Zhang M, Tao R, Zhang C, Shen Z.

Urology. 2010 Oct;76(4):902-7. doi: 10.1016/j.urology.2010.05.007. Epub 2010 Aug 14.

PMID:
20709377
[PubMed - indexed for MEDLINE]
18.

The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.

Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, Joudi FN.

BJU Int. 2009 Feb;103(4):475-9. doi: 10.1111/j.1464-410X.2008.08011.x. Epub 2008 Oct 6.

PMID:
18990174
[PubMed - indexed for MEDLINE]
19.

Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research.

Bekelman JE, Handorf EA, Guzzo T, Evan Pollack C, Christodouleas J, Resnick MJ, Swisher-McClure S, Vaughn D, Ten Have T, Polsky D, Mitra N.

Value Health. 2013 Jun;16(4):610-8. doi: 10.1016/j.jval.2013.01.005. Epub 2013 Apr 24.

PMID:
23796296
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Multiple adverse histological features increase the odds of under staging T1 bladder cancer.

Weizer AZ, Wasco MJ, Wang R, Daignault S, Lee CT, Shah RB.

J Urol. 2009 Jul;182(1):59-65; discussion 65. doi: 10.1016/j.juro.2009.02.116. Epub 2009 May 17. Erratum in: J Urol. 2009 Sep;182(3):1237.

PMID:
19447443
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk